help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosner, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosner, W.
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 6 2903
Copyright © 2001 by The Endocrine Society


Other Original Studies

LETTER TO THE EDITOR: An Extraordinarily Inaccurate Assay for Free Testosterone Is Still with Us

William Rosner

Department of Endocrinology St. Luke’s-Roosevelt Hospital Center New York, New York 10019

Address correspondence to: William Rosner, M.D., Department of Endocrinology, St. Luke’s-Roosevelt Hospital Center, 1000 Tenth Avenue, New York, New York 10019.

To the editor:

Perusing the November 2000 issue of JCE&M, I noted an article in which one of the outcome measures was serum free testosterone (1). The method used to measure serum free testosterone, a direct RIA that purports to, but does not, measure the free testosterone concentration is one whose use I decried in a letter to the editor published more than 3 yr ago (2). Not long after, Vermeulen et al. (3) published a side-by-side experimental comparison of methods for determining the concentration of free testosterone in serum. Those experiments conclusively show that the direct RIA of free testosterone is seriously inaccurate, underestimating its concentration by many-fold. To my knowledge, there are no data that contradict these conclusions. Hence, I was surprised to find that the direct assay method not only was still being used for investigative purposes, but also was being published in what is among the foremost endocrine journals in the world.

To see how pervasive this situation was, I undertook to examine the frequency with which those publishing in the journal were using this methodology.

Methods. I conducted a full text, online search, of the JCE&M (January 1998-November 2000) using the term "free testosterone." Then, I evaluated each retrieved citation containing the term and ascertained whether it revealed the use of a direct RIA for free testosterone, an alternate method for measuring free testosterone, or was not applicable (e.g. free testosterone mentioned in an editorial, a comment, a discussion, a bibliography, etc.). In addition to the foregoing, there were a number of publications in which no reference was given.

Results. A total of 116 citations were retrieved: 49 were not applicable; 11 contained no reference for the method cited; 24 used a method other than direct RIA; and 32 used the direct RIA. Of the 116 citations, 67 were suitable to address the question at hand. Thus, 48% (32 of 67) of the applicable papers used a seriously inaccurate method for estimating free testosterone and, almost as serious, 16% (11 of 67) cited no method at all.

Why would anyone choose to use this methodology? Perhaps the answer can be found in the technical bulletins of one of the companies that manufacture and sell kits that use this method. The relevant citations reveal that kits made by two companies, Diagnostic Products and Diagnostic Systems Laboratories, Inc. (DSL), account for almost all the inappropriate measurements of free testosterone in papers published in the journal during the period in question. A DSL technical bulletin (http://www. dslabs.com/techlit/4900tb2.doc) advertises: "Historically, free testosterone levels were determined by a method known as equilibrium dialysis. ... The method is cumbersome, time-consuming, and equipment intensive." Conversely, we are told, the DSL direct method is simple and rapid. The only difficulty is that "the equilibrium dialysis method gave values approximately 4 times higher than did the DSL kit." As if to compensate for the inexcusable inaccuracy, the technical bulletin and accompanying X-Y plot of RIA vs. equilibrium dialysis makes the point that the correlation coefficient is 0.92. Even this is deceiving. The points at the upper end of the DSL method are the major contributors to the fitted line. Visual examination of the plot indicates that a line through the lower points (17 of 21 points below the fitted line and 2 points above it) would have a substantially different slope than that indicated by the published fitted line. Thus, in addition to being inaccurate, this observation indicates that, compared with equilibrium dialysis, the assay is not linear. Yet, the kit remains on the market because it is easy to use.

Almost one half of the publications dealing with free testosterone, in the period under consideration, used an inaccurate assay for its measurement. Even if the (somewhat more time-consuming) procedure of equilibrium dialysis were the only alternative, the literature of science ought not to use a method so grossly inaccurate when better ones exist. We all know that there are numerous assays for hormones in serum that are method specific. However, I know of no other that has been demonstrated to be so egregiously incorrect. The journal might choose to return manuscripts that use it without further evaluation to discourage its use.

Received November 29, 2000.

References

  1. Brown GA, Vukovich MD, Martini ER, et al. 2000 Endocrine responses to chronic androstenedione intake in 30- to 56-year-old men. J Clin Endocrinol Metab. 85:4074–4080.[Abstract/Free Full Text]
  2. Rosner W. 1997 Errors in the measurement of plasma free testosterone. J Clin Endocrinol Metab. 82:2014–2015 (Letter).[Free Full Text]
  3. Vermeulen A, Verdonck L, Kaufman JM. 1999 A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 84:3666–3672.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Ann Clin BiochemHome page
G. Sartorius, L. P Ly, K. Sikaris, R. McLachlan, and D. J Handelsman
Predictive accuracy and sources of variability in calculated free testosterone estimates
Ann Clin Biochem, March 1, 2009; 46(2): 137 - 143.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
W. de Ronde, Y. T. van der Schouw, H. A.P. Pols, L. J.G. Gooren, M. Muller, D. E. Grobbee, and F. H. de Jong
Calculation of Bioavailable and Free Testosterone in Men: A Comparison of 5 Published Algorithms
Clin. Chem., September 1, 2006; 52(9): 1777 - 1784.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
T. J. Beckman, H. S. Abu-Lebdeh, and L. A Mynderse
Erectile Dysfunction and Testosterone-Reply-I
Mayo Clin. Proc., June 1, 2006; 81(6): 853 - 854.
[Full Text] [PDF]


Home page
JAMAHome page
E. L. Ding, Y. Song, V. S. Malik, and S. Liu
Sex Differences of Endogenous Sex Hormones and Risk of Type 2 Diabetes: A Systematic Review and Meta-analysis
JAMA, March 15, 2006; 295(11): 1288 - 1299.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
L. P Ly and D. J Handelsman
Empirical estimation of free testosterone from testosterone and sex hormone-binding globulin immunoassays
Eur. J. Endocrinol., March 1, 2005; 152(3): 471 - 478.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Dhindsa, S. Prabhakar, M. Sethi, A. Bandyopadhyay, A. Chaudhuri, and P. Dandona
Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 Diabetes
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5462 - 5468.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
K. Van Uytfanghe, D. Stockl, J. M. Kaufman, T. Fiers, H. A. Ross, A. P. De Leenheer, and L. M. Thienpont
Evaluation of a Candidate Reference Measurement Procedure for Serum Free Testosterone Based on Ultrafiltration and Isotope Dilution-Gas Chromatography-Mass Spectrometry
Clin. Chem., November 1, 2004; 50(11): 2101 - 2110.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
E. Nieschlag, H.M. Behre, P. Bouchard, J.J. Corrales, T.H. Jones, G.K. Stalla, S.M. Webb, and F.C.W. Wu
Testosterone replacement therapy: current trends and future directions
Hum. Reprod. Update, September 1, 2004; 10(5): 409 - 419.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. K. Miller, W. Rosner, H. Lee, J. Hier, G. Sesmilo, D. Schoenfeld, G. Neubauer, and A. Klibanski
Measurement of Free Testosterone in Normal Women and Women with Androgen Deficiency: Comparison of Methods
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 525 - 533.
[Abstract] [Full Text] [PDF]


Home page
Clin Med ResHome page
M. T. Sheehan
Polycystic Ovarian Syndrome: Diagnosis and Management
Clin. Med. Res., February 1, 2004; 2(1): 13 - 27.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Szulc, B. Claustrat, F. Marchand, and P. D. Delmas
Increased Risk of Falls and Increased Bone Resorption in Elderly Men with Partial Androgen Deficiency: The MINOS Study
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5240 - 5247.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
P. Y. Liu, A. K. Death, and D. J. Handelsman
Androgens and Cardiovascular Disease
Endocr. Rev., June 1, 2003; 24(3): 313 - 340.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
A. M. Matsumoto
Andropause: Clinical Implications of the Decline in Serum Testosterone Levels With Aging in Men
J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2002; 57(2): M76 - 99.
[Full Text]


This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosner, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosner, W.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals